The global probiotic drugs market is witnessing an unprecedented surge, evolving from simple dietary supplements to sophisticated pharmaceutical-grade therapeutic agents. As of 2024, the industry is valued at billions of dollars, driven by an increasing consumer awareness of the "gut-brain axis" and the role of the microbiome in overall health.
From North America to the Asia-Pacific region, the demand for high-stability, clinical-strength probiotics is skyrocketing. Industrial applications have expanded beyond human health into specialized sectors like high-value aquaculture, livestock performance enhancement, and companion animal wellness.
Located in the heart of China's biotech hub, Hangzhou Jeci Biochem Technology Co., Ltd. is a premier entity committed to the sales, research, and manufacturing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and high-performance nutritional products.
We pride ourselves on our robust collaborative R&D ecosystem. In China, we work in depth with leading new drug research institutes and multiple GMP-certified custom processing plants. This synergy allows us to offer not just products, but comprehensive technical solutions including technology transfer, custom manufacturing (CMO/CDMO), and exclusive regional agency services.
Our reach is truly global. We have established long-term strategic trade relations with partners in India, Southeast Asia, South Korea, and Japan. For international companies looking to penetrate the Chinese market, we provide professional registration, consulting, and channel expansion services.
The integration of AI in strain screening and micro-encapsulation technology ensures that probiotic drugs survive gastric acidity, reaching the lower GI tract with maximum CFU viability.
In Southeast Asia, probiotics are increasingly used in Aquaculture to replace antibiotics, ensuring sustainable shrimp and fish farming. In Western markets, the focus is on Pet Health and specialized geriatric probiotics.
Global buyers prioritize supply chain stability, GMP compliance, and high-potency raw materials. As a leading China factory, we address these by providing factory quality management system certification consulting.
Our drugs and microbial intermediates are utilized across critical sectors:
Our facility is equipped with state-of-the-art fermentation tanks, freeze-drying systems, and clean-room packaging lines. We are able to assemble and produce larger quantities of intermediates with precision and speed.
For our main product intermediates, we maximize our logistical and technical advantages to meet customer requirements within tight deadlines, ensuring "Just-in-Time" delivery for global supply chains.
SJ medical
